|3.42||+0.08 / +2.40%|
Data as of 4:00pm ET
|3.23||-0.19 / -5.56%|
The 3 analysts offering 12-month price forecasts for Catalyst Pharmaceutical Partners Inc have a median target of 6.00, with a high estimate of 13.00 and a low estimate of 5.00. The median estimate represents a +75.44% increase from the last price of 3.42.
The current consensus among 3 polled investment analysts is to Buy stock in Catalyst Pharmaceutical Partners Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.